ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,571,857 | -15.6% | 3,705,669 | -4.4% | 0.26% | -7.2% |
| Q2 2023 | $119,122,203 | -16.9% | 3,875,153 | -2.6% | 0.28% | -22.8% |
| Q1 2023 | $143,342,293 | +3.1% | 3,978,415 | +13.1% | 0.36% | -5.0% |
| Q4 2022 | $139,010,692 | +0.7% | 3,517,477 | +2.4% | 0.38% | -8.0% |
| Q3 2022 | $137,981,000 | -8.0% | 3,434,072 | -3.7% | 0.41% | -12.7% |
| Q2 2022 | $149,952,000 | +71.5% | 3,566,894 | +59.3% | 0.47% | +110.3% |
| Q1 2022 | $87,450,000 | -4.0% | 2,239,130 | -2.0% | 0.22% | +12.0% |
| Q4 2021 | $91,093,000 | +39.9% | 2,285,899 | +26.9% | 0.20% | +36.1% |
| Q3 2021 | $65,094,000 | -15.7% | 1,801,145 | -4.4% | 0.15% | -13.0% |
| Q2 2021 | $77,235,000 | +6088.7% | 1,884,011 | +6482.2% | 0.17% | +5533.3% |
| Q1 2021 | $1,248,000 | +144.7% | 28,623 | +180.5% | 0.00% | +200.0% |
| Q4 2020 | $510,000 | – | 10,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |